- CMR Short Reviews
- Documentation Centre
The Concept of CMR
Slides, videos and more
The most comprehensive educational website on the relationships between abdominal obesity, type 2 diabetes and cardiovascular disease
News
-
July 30, 2010 The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study. Atherosclerosis 2010;209:551-7
Patterson CC, Smith AE, Yarnell JW, Rumley A, Ben-Shlomo Y, Lowe GD.
-
July 30, 2010 Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis 2010;209:573-8
Konishi M, Sugiyama S, Sugamura K, Nozaki T, Ohba K, Matsubara J, Matsuzawa Y, Sumida H, Nagayoshi Y, Nakaura T, Awai K, Yamashita Y, Jinnouchi H, Matsui K, Kimura K, Umemura S, Ogawa H.
-
July 29, 2010 Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity. Arterioscler Thromb Vasc Biol 2010;30:1043-50
Chan DC, Watts GF, Gan S, Wong AT, Ooi EM, Barrett PH.
-
July 29, 2010 Relation between visceral fat and coronary artery disease evaluated by multidetector computed tomography. Atherosclerosis 2010;209:481-6
Marques MD, Santos RD, Parga JR, Rocha-Filho JA, Quaglia LA, Miname MH, Avila LF.
Subscribe to our Newsletter
Subscribe to our e-newsletter to get the latest scientific news, learn about new additions to our site, and receive invitations to events where you can meet with other experts and your peers.
CMR Fun Clips
Watch Dr. Cheese and the Potato family’s funny videos and learn simple notions about abdominal obesity and related health.
Calendar of Events
August 28 to September 1, 2010
Stockholm, Sweden
ESC Congress 2010
Recent Contributions
-
Expert Opinions Why are we shaped differently, and why does it matter?
Michael Jensen, MD, Division of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA
-
Expert Opinions What are the current recommendations for the management of patients at risk for type 2 diabetes?
Edward Horton, Director of Clinical Research, Joslin Diabetes Center, Boston, MA, USA
-
Expert Opinions What evidence do we have that systemic CB1 receptors are important in the pathophysiology of glycemia?
Vincenzo Di Marzo, PhD, Istituto di Chimica Biomolecolare Pozzuoli (NA), Italy
In the Spotlight
-
Expert Opinions Where should we focus our prevention efforts: in schools?
By Barbara V. Howard, PhD, Medstar Research Institute, Washington, DC, USA
-
Slide Library Impact of obesity on cardiometabolic risk: Will we lose the battle?
Richard Nesto, MD, FACC, FAHA Chair, Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, MA Associate Professor of Medicine Harvard Medical School, Boston, MA
-
Webcasts Per Björntorp/Jean Vague Lecture Award Recipient 2009
The International Chair on Cardiometabolic Risk
The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.